(Q51384965)

English

Serum asymmetric dimethylarginine (ADMA), homocysteine, vitamin B(12), folate levels, and lipid profiles in epileptic children treated with valproic acid.

scientific article published on 8 December 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21140275

Serum asymmetric dimethylarginine (ADMA), homocysteine, vitamin B(12), folate levels, and lipid profiles in epileptic children treated with valproic acid. (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21140275

0 references

1 reference

based on heuristic

inferred from title

author name string

Ozlem Ozdemir

1

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21140275

Ayten Yakut

2

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21140275

Ener Cagri Dinleyici

3

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21140275

Sultan Durmus Aydogdu

4

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21140275

Coskun Yarar

5

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21140275

Omer Colak

6

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21140275

publication date

8 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21140275

European Journal of Pediatrics

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21140275

170

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21140275

7

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21140275

873-877

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21140275

The effect of B-vitamins on hyperhomocysteinemia in patients on antiepileptic drugs.

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1366-5

21 January 2018

Homocysteine as a neurotoxin in chronic alcoholism

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1366-5

21 January 2018

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1366-5

21 January 2018

Plasma total homocysteine levels in children with type 1 diabetes: relationship with vitamin status, methylene tetrahydrofolate reductase genotype, disease parameters and coronary risk factors

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1366-5

21 January 2018

Blood homocysteine, folate and vitamin B-12 concentrations in patients with epilepsy receiving lamotrigine or sodium valproate for initial monotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1366-5

21 January 2018

Valproate as a mainstay of therapy for pediatric epilepsy

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1366-5

21 January 2018

Effects of valproate and carbamazepine on serum levels of homocysteine, vitamin B12, and folic acid

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1366-5

21 January 2018

Hyperhomocysteinemia, endothelial dysfunction, and cardiovascular risk: the potential role of ADMA.

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1366-5

21 January 2018

Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1366-5

21 January 2018

Adenosinergic modulation of homocysteine-induced seizures in mice.

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1366-5

21 January 2018

Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1366-5

21 January 2018

The C677T mutation in the methylenetetrahydrofolate reductase gene contributes to hyperhomocysteinemia in patients taking anticonvulsants

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1366-5

21 January 2018

Is asymmetric dimethylarginine responsible for the vascular events in patients under antiepileptic drug treatment?

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1366-5

21 January 2018

Effects of common anti-epileptic drug monotherapy on serum levels of homocysteine, vitamin B12, folic acid and vitamin B6.

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1366-5

21 January 2018

Serum lipids in epileptic children treated with carbamazepine and valproate.

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1366-5

21 January 2018

Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1366-5

21 January 2018

Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1366-5

21 January 2018

Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1366-5

21 January 2018

Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1366-5

21 January 2018

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

1 reference

https://api.crossref.org/works/10.1007%2FS00431-010-1366-5

21 January 2018

Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21140275

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21140275

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of anticonvulsant drugs on plasma total cholesterol, high-density lipoprotein cholesterol, and apolipoproteins A and B in children with epilepsy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21140275

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Total cholesterol, high-density lipoprotein cholesterol, and triglycerides in children receiving antiepileptic drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/21140275

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-epileptic drug treatment in children: hyperhomocysteinaemia, B-vitamins and the 677C-->T mutation of the methylenetetrahydrofolate reductase gene

1 reference

https://pubmed.ncbi.nlm.nih.gov/21140275

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lipids, lipoproteins, apolipoproteins, selected trace elements and minerals in the serum of children on valproic acid monotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21140275

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21140275

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21140275

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evolution of serum lipids and lipoprotein (a) levels in epileptic children treated with carbamazepine, valproic acid, and phenobarbital

1 reference

https://pubmed.ncbi.nlm.nih.gov/21140275

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperhomocysteinemia: an independent risk factor for vascular disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21140275

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00431-010-1366-5

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21140275

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21140275

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51384965&oldid=2210839660"